103
Participants
Start Date
January 31, 2008
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Droxidopa
100 mg, oral, three times per day 200 mg, oral, three times per day 300 mg, oral, three times per day 400 mg, oral, three times per day 500 mg, oral, three times per day 600 mg, oral, three times per day
Placebo
100 mg, oral, three times per day 200 mg, oral, three times per day 300 mg, oral, three times per day 400 mg, oral, three times per day 500 mg, oral, three times per day 600 mg, oral, three times per day
Baker Heart Research Institute, Melbourne
Austin Hospital, Heidelburg
Royal Adelaide Hospital, Adelaide
NYU Medical Center, New York
Columbia University Neurological institute of NY, New York
Kingston Neurological Associates, PC, Kingston
University of Rochester, Rochester
University of Maryland Hospital, Baltimore
Wake Forest University, Winston-Salem
Duke University Medical Center, Durham
Medical Associates of North Georgia, Canton
Mayo Jacksonville Florida Department of Neurology, Jacksonville
Southeastern Integrated Medical, Gainesville
University of Miami Miller School of Medicine, Miami
Parkinson's Disease & Movment Disorder Center, Boca Raton
University of South Florida, Tampa
University of Alabama at Birmingham, Birmingham
Vanderbilt University, Nashville
University of Louisville, Louisville
University Hospitals Case Medical Center, Cleveland
Cleveland Clinic, Cleveland
University of Cincinnati, Cincinnati
JWM Neurology, Indianapolis
Indiana Medical Research, Elkhart
Henry Ford Health System, Southfield
Mayo Clinic Rochester, Rochester
North Chicago VA Medical Center, North Chicago
Saint Mary of Nazareth Hospital Center, Chicago
Washington University Medical Center, St Louis
Kansas City Bone and Joint, PA, Overland Park
COR Clinical Research, LLC, Oklahoma City
East Texas Medical Center - Neurological Institute Movment Disorders Center, Tyler
Scott & White Memorial Hospital & Clinic, Temple
Jacinto Medical Group, PA, Baytown
Scott & White Healthcare - Round Rock, Round Rock
Electrophysiology Associates, Colorado Springs
Xenoscience Inc., Phoenix
Dedicated Clinical Research, Litchfield Park
Sun Health Research Institute, Sun City
The Parkinson's and Movement Disorders Institute, Fountain Valley
Pacific Neuroscience Medical Group, Oxnard
The Parkinson's Institute, Sunnyvale
The Oregon Clinic, Portland
Beth Israel Deaconess Medical Center, Boston
University of Massachusetts Worcester, Worcester
New Jersey Neuroscience Institute, Edison
UT Southwestern Medical Center, Dallas
McMaster University, Hamilton
Centre for Movement Disorders, Markham
Parkinson's & Neurodegenerative Disorders Clinic, Ottawa
SMBD Jewish General Hospital - Department of Neurology, Montreal
Quebec Memory and Motor Skills Disorders Clinic, Québec
Auckland Hospital, Grafton Auckland
Van der Veer Institute for Parkinson's Disease and Movement Disorders, Christchurch
Lead Sponsor
Chelsea Therapeutics
INDUSTRY